NYSE:NBY

NovaBay Pharmaceuticals (NBY) Stock Forecast, Price & News

$0.65

0.00 (0.00%)

(As of 05/31/2023 ET)

Compare

Today's Range: $0.61
▼
$0.65
50-Day Range: N/A
52-Week Range: $0.61
▼
$12.64

Volume: 145,257 shs
Average Volume: 291,488 shs
Market Capitalization: $1.77 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Profile Chart Competitors Financials Headlines SEC Filings Social Media

About NovaBay Pharmaceuticals

NovaBay Pharmaceuticals, Inc. engages in the development and sales of scientifically-created and clinically-proven eyecare and skincare. Its products include Avenova, NeutroPhase, CelleRx, and DERMAdoctor. The company was founded on January 19, 2000 and is headquartered in Emeryville, CA.

Receive NBY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NovaBay Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

NBY Stock News Headlines

May 27, 2023 | americanbankingnews.com

NovaBay Pharmaceuticals (NYSE:NBY) Coverage Initiated at StockNews.com

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive NBY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NovaBay Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

NBY Company Calendar

Today: 6/01/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Pharmaceutical preparations
Sub-Industry: N/A
Sector: Medical
Current Symbol: NYSE:NBY
CUSIP: N/A
CIK: 1389545
Web: novabay.com
Phone: (510) 899-8800
Fax: 510-474-1577
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($10.0751)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-10,610,000.00
Net Margins: -89.72%
Pretax Margin: -89.72%
Return on Equity: -116.85%
Return on Assets: -65.13%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 2.24
Quick Ratio: 1.38

Sales & Book Value

Annual Sales: $14.40 million
Price / Sales: 0.12
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $2.17 per share
Price / Book: 0.30

Miscellaneous

Outstanding Shares: 2,730,000
Free Float: 2,694,000
Market Cap: $1.77 million
Optionable: Not Optionable
Beta: 2.72

Key Executives

Justin M. Hall
President, CEO, Director & General Counsel

Tommy Law
Chief Financial Officer, Treasurer & Controller

Audrey G. Kunin
Director & Chief Product Officer

Key Competitors

View All Competitors

NBY Stock - Frequently Asked Questions

How have NBY shares performed in 2023?: NovaBay Pharmaceuticals' stock was trading at $0.6796 at the beginning of the year. Since then, NBY stock has decreased by 4.4% and is now trading at $0.6499.
View the best growth stocks for 2023 here.
What other stocks do shareholders of NovaBay Pharmaceuticals own?: Based on aggregate information from My MarketBeat watchlists, some companies that other NovaBay Pharmaceuticals investors own include OpGen (OPGN) and Abbott Laboratories (ABT).
What is NovaBay Pharmaceuticals' stock symbol?: NovaBay Pharmaceuticals trades on the New York Stock Exchange (NYSE) under the ticker symbol "NBY."

How do I buy shares of NovaBay Pharmaceuticals?: Shares of NBY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is NovaBay Pharmaceuticals' stock price today?: One share of NBY stock can currently be purchased for approximately $0.65.
How much money does NovaBay Pharmaceuticals make?: NovaBay Pharmaceuticals (NYSE:NBY) has a market capitalization of $1.77 million and generates $14.40 million in revenue each year. The company earns $-10,610,000.00 in net income (profit) each year or ($10.0751) on an earnings per share basis.
How can I contact NovaBay Pharmaceuticals?: NovaBay Pharmaceuticals' mailing address is 2000 POWELL STREET SUITE 1150, EMERYVILLE CA, 94608. The official website for the company is novabay.com. The company can be reached via phone at (510) 899-8800, via email at jcain@lhai.com, or via fax at 510-474-1577.

This page (NYSE:NBY) was last updated on 6/1/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial